quantisnow
FeedTopReportsPricing
⌘K
Live feed
13:05:14·31d
SECFiling
Stryker Corporation logo

SEC Form DEF 14A filed by Stryker Corporation

SYK· Stryker Corporation
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • SYK
    Stryker Corporation
    Health Care

Recent analyst ratings

  • Apr 13UpdateLeerink Partners$410.00
  • Feb 20UpdateWilliam Blair-
  • Jan 27UpdateTD Cowen$387.00
  • Jan 6UpdateRaymond James$418.00
  • Dec 19UpdateCitizens JMP$440.00
  • Sep 18UpdateRothschild & Co Redburn$420.00

Related

  • PR7d
    Berger Montague PC Investigates Stryker Corporation's Board of Directors for Breach of Fiduciary Duty (NYSE: SYK)
  • ANALYST10d
    Leerink Partners initiated coverage on Stryker with a new price target
  • PR10d
    Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
  • SEC14d
    Amendment: Stryker Corporation filed SEC Form 8-K: Regulation FD Disclosure
  • PR22d
    Stryker to announce financial results for its first quarter of fiscal year 2026
  • PR23d
    Stryker names Nick Mead Vice President, Investor Relations
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Stryker Corporation
  • INSIDER30d
    SEC Form 4 filed by Stiles Spencer S
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022